Nicolas Sax

Medicine · Health Sciences

14h-index681citations62works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(36), Immunotherapy and Immune Responses(33), Immune Cell Function and Interaction(18), T-cell and B-cell Immunology(8), RNA Interference and Gene Delivery(8)

Publications62 total

Clonal differentiation of plasmablasts undergoing oral immunotherapy in patients with milk allergy
Allergology International·2025Open Access
Infiltration of Innate Immune Cells into Tumors By Polatuzumab Vedotin Treatment Contributes to Its Antitumor Effect in Xenograft and Syngeneic Mouse Models
Blood·2024· 1 citedOpen Access
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes
Science Advances·2023· 9 citedOpen Access
Tumor-derived semaphorin 4A improves PD-1–blocking antibody efficacy by enhancing CD8 <sup>+</sup> T cell cytotoxicity and proliferation
Science Advances·2023· 25 citedOpen Access
Supplementary Table S9 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Table S1 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Table S3 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Table S2 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Table S4 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Table S6. from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Figure S4 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Figure S6 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Table S5 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Figure S2 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Table S3 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Figure S1 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Figure S4 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Data from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Figure S1 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
Supplementary Figure S6 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Kazuo Yamashita(31), Masahito Kawazu(25), Toshihide Ueno(25), Hiroyuki Mano(25), Hiroyoshi Nishikawa(25), Yosuke Togashi(25), Joji Nagasaki(24), Takashi Inozume(24), Takao Morinaga(24), Takehiro Ohnuma(24), Tatsuyoshi Kawamura(24), Akihito Kawazoe(24), Kohei Shitara(24), Youki Ueda(23), Shusuke Kawashima(23), Jason Lin(23), Yuuki Ohara(23), Takeshi Kuwata(23), Hiroki Yukami(23), Akiko Honobe‐Tabuchi(23)